Boehringer Ingelheim (Taiwan)
- Research works
- 68 ▼ 15% vs 2013–17
- Citations
- 3.2k 47.3 per fractional work
- Top-10% rate
- 18.5% record average 16.5%
- Open access
- 41% world 28%
Not ranked overall: Boehringer Ingelheim (Taiwan) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Chemistry, 10.8×. Every wedge is a field page.
- Chemistry 10.8×
- Immunology and Microbiology 10.6×
- Medicine 2.6×
- Biochemistry, Genetics and Molecular Biology 2.2×
- Earth and Planetary Sciences 1.7×
- Neuroscience 0.5×
- Environmental Science 0.4×
- Economics, Econometrics and Finance 0.3×
- Physics and Astronomy 0.3×
- Materials Science 0.2×
- Computer Science 0.1×
- Engineering 0.1×
- Health Professions 0.1×
Which keywords describe research at Boehringer Ingelheim (Taiwan)?
By fractional works in all years, weighted toward what it does more of than the world: Global Burden, Treatment, Medicinal Chemistry, TGF-ß, Diagnosis, Inflammation, Monoclonal Antibodies and Clinical Trials.
- Cycloaddition Reactions
- Interstitial Lung Disease
- Regulatory T Cells
- Glycemic Control
- Allergic Diseases
- Fc Receptors
- Virtual Screening
- Drug Target Identification
- Glycosylation
- spirometry
- Pharmacokinetics
- Genetics
- Heterocyclic Compounds
- Clinical Guidelines
- Nanoparticles
- Cardiovascular Disease
- Clinical Trials
- Medicinal Chemistry
- Diagnosis
- Inflammation
- Epidemiology
- Treatment
- Global Burden
- TGF-ß
- Monoclonal Antibodies
- Management
- Synthesis
- Molecular Docking
- COPD
- Inhaler Devices
- Pulmonary Drug Delivery
- Therapeutic Antibodies
- Heart Failure
- Fibrosis
- Antibody Engineering
- Targeted Therapy
- Asthma
- Insulin Therapy
- Immune System
- Diabetes Mellitus
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology5▲ 1.83×19 topics
- Inflammation5▲ 2.9×17 topics
- Treatment4▲ 4.6×13 topics
- Diagnosis4▲ 5.0×10 topics
- Global Burden4▲ 9.6×6 topics
- Medicinal Chemistry3▲ 12×6 topics
- TGF-ß3▲ 25×4 topics
- Clinical Trials3▲ 6.5×6 topics
- Monoclonal Antibodies3▲ 26×3 topics
- Cardiovascular Disease2▲ 3.2×10 topics
- Management2▲ 4.7×5 topics
- Nanoparticles2▲ 2.7×4 topics
- Synthesis2▲ 6.1×7 topics
- Clinical Guidelines2▲ 11×3 topics
- Molecular Docking2▲ 24×2 topics
- Heterocyclic Compounds2▲ 20×5 topics
- COPD2▲ 49×1 topic
- Genetics2▲ 3.9×3 topics
- Inhaler Devices2▲ 102×1 topic
- Pharmacokinetics2▲ 11×4 topics
- Pulmonary Drug Delivery2▲ 102×1 topic
- spirometry2▲ 49×1 topic
- Therapeutic Antibodies2▲ 22×2 topics
- Glycosylation2▲ 13×3 topics
- Heart Failure2▲ 6.2×5 topics
- Drug Target Identification2▲ 38×1 topic
- Fibrosis2▲ 13×4 topics
- Virtual Screening2▲ 38×1 topic
- Antibody Engineering2▲ 26×1 topic
- Fc Receptors2▲ 26×1 topic
- Targeted Therapy2▲ 11×4 topics
- Allergic Diseases2▲ 30×1 topic
- Asthma2▲ 19×1 topic
- Glycemic Control2▲ 17×3 topics
- Insulin Therapy2▲ 21×3 topics
- Regulatory T Cells2▲ 22×3 topics
- Immune System2▲ 6.5×3 topics
- Interstitial Lung Disease2▲ 41×2 topics
- Diabetes Mellitus1▲ 9.2×6 topics
- Cycloaddition Reactions1▲ 45×3 topics
Which research topics does Boehringer Ingelheim (Taiwan) publish most on?
By volume in 2022–2025: Psoriasis: Treatment and Pathogenesis, Monoclonal and Polyclonal Antibodies Research, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis and Dialysis and Renal Disease Management.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Psoriasis: Treatment and Pathogenesis Immunology 1 works
- 2 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
- 3 Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Pulmonary and Respiratory Medicine 1 works
- 4 Dialysis and Renal Disease Management Nephrology 0 works
- 5 Blood Pressure and Hypertension Studies Cardiology and Cardiovascular Medicine 0 works
- 6 Advanced Biosensing Techniques and Applications Molecular Biology 0 works
- 7 Biosimilars and Bioanalytical Methods Immunology 0 works
- 8 Pharmaceutical studies and practices Pediatrics, Perinatology and Child Health 0 works
- 9 Advanced NMR Techniques and Applications Spectroscopy 0 works
- 10 Diet and metabolism studies Physiology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Boehringer Ingelheim (Taiwan)'s research output changed?
Output in 2018–2022 was 15% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Taipei
- National Taiwan University
- National Taiwan University of Science and Technology
- National Taiwan University Hospital
- National Taipei University of Technology
- Academia Sinica
- Chang Gung Memorial Hospital
- National Taiwan Normal University
- Taipei Veterans General Hospital
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.